Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,658 | 232 | 92.8% |
| Education | $441.82 | 7 | 7.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,228 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $953.24 | 47 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $933.19 | 18 | $0 (2024) |
| Incyte Corporation | $426.88 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $397.38 | 18 | $0 (2024) |
| GENZYME CORPORATION | $320.27 | 7 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $252.15 | 9 | $0 (2024) |
| LEO Pharma Inc. | $200.85 | 5 | $0 (2024) |
| Amgen Inc. | $166.03 | 8 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $150.22 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,032 | 69 | ABBVIE INC. ($522.30) |
| 2023 | $1,793 | 80 | ABBVIE INC. ($397.62) |
| 2022 | $1,717 | 77 | Janssen Biotech, Inc. ($364.93) |
| 2021 | $558.06 | 13 | Janssen Biotech, Inc. ($141.84) |
All Payment Transactions
239 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: IMMUNOLOGY | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $13.62 | General |
| Category: Dermatology | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.67 | General |
| Category: Immunology | ||||||
| 12/04/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Dermatology | ||||||
| 11/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: ONCOLOGY | ||||||
| 11/13/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $6.50 | General |
| Category: Dermatology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.14 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Lilly USA, LLC | OLUMIANT (Drug) | Food and Beverage | In-kind items and services | $18.69 | General |
| Category: Immunology | ||||||
| 10/30/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.15 | General |
| Category: Immunology | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $28.43 | General |
| Category: Dermatology | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: DERMATOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | BLU-U (Medical Supply), Odomzo | Food and Beverage | In-kind items and services | $53.44 | General |
| Category: Dermatology | ||||||
| 09/26/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.97 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,115 | 1,568 | $175,646 | $68,455 |
| 2022 | 14 | 978 | 1,272 | $150,753 | $57,203 |
| 2021 | 11 | 844 | 1,218 | $145,810 | $56,372 |
| 2020 | 11 | 633 | 824 | $95,200 | $32,661 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 382 | 542 | $67,807 | $26,913 | 39.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 131 | 159 | $25,036 | $10,282 | 41.1% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 117 | 133 | $18,626 | $6,830 | 36.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 120 | 154 | $14,281 | $4,949 | 34.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 59 | 69 | $12,132 | $4,846 | 39.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $9,702 | $3,357 | 34.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 20 | 30 | $7,471 | $2,613 | 35.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 74 | $5,807 | $2,464 | 42.4% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 41 | 78 | $5,417 | $2,347 | 43.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 28 | 29 | $5,075 | $2,064 | 40.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 67 | 214 | $1,986 | $898.89 | 45.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 23 | 23 | $2,307 | $890.15 | 38.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 241 | 300 | $37,262 | $16,370 | 43.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 159 | $29,514 | $9,415 | 31.9% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 89 | 92 | $15,524 | $6,884 | 44.3% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 118 | 157 | $17,661 | $5,406 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 63 | 67 | $10,801 | $4,605 | 42.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 60 | 63 | $8,994 | $3,739 | 41.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 69 | 79 | $7,006 | $2,470 | 35.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 21 | 26 | $4,718 | $2,127 | 45.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 31 | 31 | $4,852 | $2,021 | 41.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 24 | 32 | $2,282 | $1,070 | 46.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $2,820 | $983.02 | 34.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 61 | 215 | $5,314 | $825.53 | 15.5% |
| 11105 | Punch biopsy, each additional skin growth | Office | 2022 | 18 | 18 | $1,434 | $712.76 | 49.7% |
About David Foster, R.P.A.-C
David Foster, R.P.A.-C is a Physician Assistant healthcare provider based in Albany, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1285695957.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Foster, R.P.A.-C has received a total of $6,100 in payments from pharmaceutical and medical device companies, with $2,032 received in 2024. These payments were reported across 239 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($5,658).
As a Medicare-enrolled provider, Foster has provided services to 3,570 Medicare beneficiaries, totaling 4,882 services with total Medicare billing of $214,691. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Albany, NY
- Active Since 03/31/2006
- Last Updated 06/17/2022
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1285695957
Products in Payments
- DUPIXENT (Biological) $1,235
- TREMFYA (Drug) $958.63
- SKYRIZI (Biological) $878.66
- OPZELURA (Drug) $426.88
- RINVOQ (Biological) $268.68
- Sotyktu (Drug) $252.15
- ILUMYA (Biological) $244.10
- ADBRY (Biological) $200.85
- Otezla (Drug) $166.03
- iDose (Device) $135.65
- SILIQ (Drug) $127.36
- VTAMA (Drug) $117.76
- LIBTAYO (Biological) $108.02
- Cimzia (Drug) $105.56
- REMICADE (Biological) $102.13
- Ilumya (Biological) $99.84
- EUCRISA (Drug) $77.64
- COSENTYX (Biological) $76.14
- TALTZ (Drug) $57.70
- HUMIRA (Biological) $55.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Albany
Richard Dalaba, Rpa-C, RPA-C
Physician Assistant — Payments: $25,244
Michael Weinberg, Rpa-C, RPA-C
Physician Assistant — Payments: $15,507
Brandon Glow, Pa, PA
Physician Assistant — Payments: $12,434
Mr. Richard Clark, Rpa-C, RPA-C
Physician Assistant — Payments: $12,243
Brittany Baxter
Physician Assistant — Payments: $11,994
Maura Corbett, Pa-C, PA-C
Physician Assistant — Payments: $10,670